Abstract
Anti-PD-1 or anti-PD-L1 blocking monoclonal antibodies (mAbs) have shown potent anti-tumor effects in adult cancer patients and clinical studies have ......
小提示:本篇文献需要登录阅读全文,点击跳转登录